BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6604229)

  • 21. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells.
    Miller JD; Peters M; Oran AE; Beresford GW; Harrington L; Boss JM; Altman JD
    J Immunol; 2002 Jul; 169(2):693-701. PubMed ID: 12097371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
    J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.
    Suzuki R; Handa K; Itoh K; Kumagai K
    J Immunol; 1983 Feb; 130(2):981-7. PubMed ID: 6600260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the heterogeneity of murine natural killer cells.
    Minato N; Reid L; Bloom BR
    J Exp Med; 1981 Sep; 154(3):750-62. PubMed ID: 6168724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assignment of human natural killer (NK)-like cells to the T cell lineage. Single allospecific T cell clones lyse specific or NK-sensitive target cells via distinct recognition structures.
    Moretta A; Pantaleo G; Mingari MC; Melioli G; Moretta L; Cerottini JC
    Eur J Immunol; 1984 Feb; 14(2):121-5. PubMed ID: 6230242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphokine-activated killer cells in mouse bone marrow chimaeras. The relationship to natural killer cells and to alloreactive cytotoxic T cells.
    Sihvola M
    Scand J Immunol; 1985 Nov; 22(5):479-88. PubMed ID: 2867599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dependency on intercellular adhesion molecule recognition and local interleukin-2 provision in generation of an in vivo CD8+ T-cell immune response to murine myeloid leukemia.
    Boyer MW; Orchard PJ; Gorden KB; Anderson PM; Mclvor RS; Blazar BR
    Blood; 1995 May; 85(9):2498-506. PubMed ID: 7727779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
    Peace DJ; Kern DE; Schultz KR; Greenberg PD; Cheever MA
    J Immunol; 1988 May; 140(10):3679-85. PubMed ID: 2896213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation of the role of soluble cytotoxic factors and reactive oxygen intermediates in lysis by NK cells.
    Wayner EA; Brooks CG
    Adv Exp Med Biol; 1985; 184():221-38. PubMed ID: 2412413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fucose-activated killer (FAK) cells: anomalous killers with augmented cytotoxic activity.
    Stanková J; Rola-Pleszczynski M
    J Immunol; 1985 Dec; 135(6):3719-28. PubMed ID: 2415584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
    Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
    Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
    Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
    J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clonal analysis of human peripheral blood lymphocytes displaying natural killer-like activity.
    Roberts K; Moore M
    Eur J Immunol; 1985 May; 15(5):448-56. PubMed ID: 3873338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. II. Development of syngeneic cytotoxicity in the absence of specific antigenic stimulation.
    Claesson MH; Miller RG
    J Immunol; 1985 Feb; 134(2):684-90. PubMed ID: 2578160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A murine cytotoxic T lymphocyte clone from the intestinal mucosa that is antigen specific for proliferation and displays broadly reactive inducible cytotoxic activity.
    Klein JR; Lefrancois L; Kagnoff MF
    J Immunol; 1985 Dec; 135(6):3697-703. PubMed ID: 2415582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
    Parhar RS; Lala PK
    J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells.
    Fresa KL; Karjalainen HE; Tevethia SS
    J Immunol; 1987 Feb; 138(4):1215-20. PubMed ID: 3027174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen-specific, but not natural killer, activity of T cell receptor-gamma delta cytotoxic T lymphocyte clones involves secretion of N alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester serine esterase and influx of Ca2+ ions.
    Spits H; Paliard X; De Vries JE
    J Immunol; 1989 Sep; 143(5):1506-11. PubMed ID: 2474601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.
    Hercend T; Griffin JD; Bensussan A; Schmidt RE; Edson MA; Brennan A; Murray C; Daley JF; Schlossman SF; Ritz J
    J Clin Invest; 1985 Mar; 75(3):932-43. PubMed ID: 3884668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.